Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1476328Generated: November 1, 2026

(R)-4-(4-((tert-Butyldimethylsilyloxy)(4'-chlorobiphenyl-2-yl)methyl)piperidin-1-yl)benzoic acid → HCID 86661879, compound

https://huagongshe.com/reaction/1476328

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(R)-4-(4-((tert-Butyldimethylsilyloxy)(4'-chlorobiphenyl-2-yl)methyl)piperidin-1-yl)benzoic acidHCID 58080201—
ReactantHCID 66723495HCID 66723495—
ProductHCID 86661879HCID 8666187990.9%

Reaction Steps

The title product (134 mg, yield: 77%) was prepared using a procedure similar to the one described for the synthesis of INTERMEDIATE 33. (R)-4-(4-((tert-Butyldimethylsilyloxy)(4′-chlorobiphenyl-2-yl)methyl)piperidin-1-yl)benzoic acid (INTERMEDIATE 13, 67.7 mg, 0.13 mmol) and 4-((R)-4-((R)-3-((tert-butyldiphenylsilyloxy)methyl)morpholino)-1-(phenylthio)butan-2-ylamino)-3-(trifluoromethylsulfonyl)benzenesulfonamide (INTERMEDIATE 109, 94.4 mg, 0.11 mmol) were used as starting materials. The resulting product was purified by column chromatography (ISCO, 12 g silica gel column, eluting with 0→30% EtOAc/hexanes), providing the title compound.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09018381B2
Source datasetuspto-grants-2015_04
ORD IDord-5cf6ffb11d81441d8c3bf6cd5aa7771c
Source noteuspto-grants-2015_04